Cerus Corporation Announces Follow-On Award Of $8.7M Amendment To Original $9.1M Contract By U.S. DOD For Development Of Pathogen Reduced, Lyophilized Cryoprecipitate
Portfolio Pulse from Benzinga Newsdesk
Cerus Corporation has received an $8.7 million follow-on award from the U.S. Department of Defense (DOD) to develop pathogen-reduced, lyophilized cryoprecipitate. This amendment comes after the original $9.1 million contract.
June 05, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cerus Corporation receives an $8.7 million follow-on award from the U.S. DOD, increasing the total contract value to $17.8 million.
The follow-on award of $8.7 million from the U.S. DOD is a positive development for Cerus Corporation. It demonstrates the DOD's continued confidence in the company's ability to develop pathogen-reduced, lyophilized cryoprecipitate. This increased funding will likely boost the company's research and development efforts, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100